Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2024
Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners Foundation
S Peters, S Loi, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2015
Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trial
M Jamal-Hanjani, R A'Hern, N J Birkbak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2018
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
J Mateo, D Chakravarty, R Dienstmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 5, 2016
Consensus on precision medicine for metastatic cancers: a report from the MAP conference
C Swanton, J-C Soria, A Bardelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 10, 2019
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)
S Peters, U Dafni, M Boyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 23, 2020
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic
A Sud, M E Jones, J Broggio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 4, 2015
Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome
F Favero, N McGranahan, M Salm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2019
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
S Trebeschi, S G Drago, N J Birkbak, et al.
Oncogene
|
March 3, 2015
SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair
N Kanu, E Grönroos, P Martinez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2016
International cancer seminars: a focus on kidney cancer
G Scelo, J N Hofmann, R E Banks, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2024
Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners Foundation
S Peters, S Loi, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2015
Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trial
M Jamal-Hanjani, R A'Hern, N J Birkbak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2018
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
J Mateo, D Chakravarty, R Dienstmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 5, 2016
Consensus on precision medicine for metastatic cancers: a report from the MAP conference
C Swanton, J-C Soria, A Bardelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 10, 2019
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)
S Peters, U Dafni, M Boyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 23, 2020
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic
A Sud, M E Jones, J Broggio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 4, 2015
Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome
F Favero, N McGranahan, M Salm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2019
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
S Trebeschi, S G Drago, N J Birkbak, et al.
Oncogene
|
March 3, 2015
SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair
N Kanu, E Grönroos, P Martinez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2016
International cancer seminars: a focus on kidney cancer
G Scelo, J N Hofmann, R E Banks, et al.
Page
of 7